skip to Main Content

Gary Nabors, Ph.D. Joins Integrated BioTherapeutics Inc. as Executive Vice President and Chief Development Officer

Integrated BioTherapeutics Inc. (IBT), a Maryland company specializing in emerging infectious diseases, announced today Dr. Gary Nabors has joined the firm as Executive Vice President and Chief Development Officer. IBT is a biotechnology company focused on the development of vaccines and immunotherapeutics.

“We are pleased to welcome Dr. Nabors to the IBT team. His extensive experience in advanced development of infectious diseases products will bring great value to IBT’s efforts to transition its lead product candidates into the clinic,” said Dr. M. Javad Aman, President of IBT. “Dr. Nabors’ role as head of product development will enable IBT to effectively translate its discovery pipeline into practical solutions for infectious diseases.”



Back To Top